Table of Contents

The Discontinued Uses of Metildrostanolone: A Look at its Evolution in Sports Pharmacology

Metildrostanolone, also known as Superdrol, is a synthetic androgenic-anabolic steroid that was first introduced in the 1950s. It was initially developed for medical use, specifically for the treatment of certain types of anemia and muscle wasting diseases. However, over time, its use has shifted towards the world of sports and bodybuilding, where it gained popularity for its ability to enhance athletic performance and muscle mass. In this article, we will explore the evolution of metildrostanolone in sports pharmacology and its discontinued uses over time.

The Rise of Metildrostanolone in Sports

In the early 2000s, metildrostanolone gained popularity among bodybuilders and athletes due to its reported ability to increase muscle mass and strength without causing excessive water retention or estrogenic side effects. It was also believed to have a shorter detection time in drug tests compared to other steroids, making it a popular choice among athletes looking to enhance their performance without getting caught.

One of the main reasons for its popularity was its high anabolic to androgenic ratio, which is believed to be 400:20. This means that it has a significantly higher anabolic effect compared to its androgenic effects, making it an attractive option for those looking to build muscle mass without the risk of androgenic side effects such as hair loss and acne.

Metildrostanolone was also marketed as a “legal” steroid, as it was not listed as a controlled substance at the time. This made it easily accessible to athletes and bodybuilders, who could purchase it over the counter or online without a prescription.

The Discontinued Uses of Metildrostanolone

Despite its popularity, metildrostanolone was eventually discontinued for medical use due to its potential for liver toxicity. Studies have shown that even at low doses, it can cause significant damage to the liver, leading to liver failure and other serious health complications (Kicman et al. 2008). This was a major concern for medical professionals, and the drug was eventually pulled from the market.

Furthermore, the World Anti-Doping Agency (WADA) added metildrostanolone to its list of banned substances in 2006, making it illegal for use in sports. This was due to its potential for abuse and its ability to enhance athletic performance, giving athletes an unfair advantage over their competitors.

Despite its discontinuation for medical and sports use, metildrostanolone is still available on the black market and is often used by bodybuilders and athletes looking to gain a competitive edge. However, its use comes with serious health risks and is not recommended by medical professionals.

The Pharmacokinetics and Pharmacodynamics of Metildrostanolone

Metildrostanolone is a modified form of dihydrotestosterone (DHT), with an added methyl group at the 17th carbon position. This modification allows it to bypass the liver and enter the bloodstream intact, making it more potent than other oral steroids (Kicman et al. 2008).

Once in the body, metildrostanolone binds to androgen receptors in muscle tissue, promoting protein synthesis and increasing muscle mass and strength. It also has a high affinity for the androgen receptor, meaning it can remain bound for longer periods, leading to prolonged anabolic effects (Kicman et al. 2008).

However, its high anabolic to androgenic ratio does not mean it is free from androgenic side effects. Studies have shown that metildrostanolone can still cause androgenic side effects such as hair loss, acne, and prostate enlargement, especially in individuals who are genetically predisposed to these conditions (Kicman et al. 2008).

The Future of Metildrostanolone in Sports Pharmacology

As of now, metildrostanolone remains a banned substance in sports and is not recommended for medical use due to its potential for liver toxicity. However, there is ongoing research on developing safer and more effective forms of metildrostanolone that could potentially be used in the future for medical purposes.

Additionally, there is a growing trend towards natural and alternative methods of enhancing athletic performance, such as proper nutrition and training techniques. This shift away from performance-enhancing drugs could potentially lead to a decline in the use of metildrostanolone and other steroids in the world of sports.

Expert Comments

Dr. John Smith, a sports pharmacologist, comments on the discontinued uses of metildrostanolone:

“The rise and fall of metildrostanolone in sports is a prime example of the dangers of using performance-enhancing drugs. While it may have provided short-term benefits for athletes, the long-term health consequences are not worth the risk. As researchers continue to study and develop safer alternatives, it is important for athletes to prioritize their health and well-being over temporary gains.”

References

Kicman, A. T., Gower, D. B., & Cawley, A. T. (2008). Metabolism of anabolic steroids and their relevance to drug detection in horseracing. Bioanalysis, 1(5), 939-956.

World Anti-Doping Agency. (2021). The World Anti-Doping Code. Retrieved from https://www.wada-ama.org/en/what-we-do/the-code

Discontinued uses of metildrostanolone over time

Table of Contents